|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects
|
Arlene Weintraub |
02/06/12 |
National
|
|
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy
|
Bruce V. Bigelow |
02/03/12 |
San Diego
|
|
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says
|
Luke Timmerman |
02/01/12 |
Boston
|
|
Four Themes to Watch in Personalized Medicine
|
Jonathan Sheffi |
01/30/12 |
San Francisco
|
|
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel
|
Luke Timmerman |
01/30/12 |
Seattle
|
|
2012 Venture Outlook: Some Bright Spots and Some Gloom
|
Bruce V. Bigelow |
01/27/12 |
National
|
|
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers
|
Erin Kutz |
01/27/12 |
Boston
|
|
Millennium Wins FDA OK for New Velcade, Looks to Fend Off Onyx
|
Luke Timmerman |
01/23/12 |
Boston
|
|
Millennium, Looking to Fend Off Onyx, Awaits FDA Word on New Velcade
|
Luke Timmerman |
01/20/12 |
Boston
|
|
SD Life Sciences News: Auspex, BrainCells, and J&J’s Startup Center
|
Bruce V. Bigelow |
01/19/12 |
San Diego
|
|
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs
|
Arlene Weintraub |
01/19/12 |
New York
|
|
Frazier Healthcare Aims for First Biotech VC Fund After Financial Crisis
|
Luke Timmerman |
01/19/12 |
Seattle
|
|
FDA’s Shuren Makes West Coast Swing, Talks About Regulatory Reform
|
Bruce V. Bigelow |
01/18/12 |
National
|
|
J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’
|
Luke Timmerman |
01/18/12 |
San Diego
|
|
Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks
|
Luke Timmerman |
01/17/12 |
National
|
|
Me-Too Drugs
|
Kleanthis Xanthopoulos |
01/11/12 |
San Diego
|
|
The Situation at the FDA: We Are All to Blame
|
Bryan Roberts |
01/10/12 |
San Francisco
|
|
Canaan Partners Survives VC Turmoil, Raises New $600M Tech/Biotech Fund
|
Luke Timmerman |
01/09/12 |
San Francisco
|
|
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
|
Luke Timmerman |
01/09/12 |
National
|
|
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More
|
Bruce V. Bigelow |
01/06/12 |
San Diego
|
|
Mirador Biomedical Gets FDA Green Light to Expand Use of Digital Sensor
|
Luke Timmerman |
01/05/12 |
Seattle
|
|
JeNu Biosciences Raises $1.5M for Ultrasound to “Put Good Things in Skin”
|
Luke Timmerman |
01/03/12 |
Seattle
|
|
VelQuest Bought by Accelrys for $35M
|
Gregory T. Huang |
01/03/12 |
Boston
|
|
The Top 10 Traffic-Getting Stories at Xconomy San Diego
|
Bruce V. Bigelow |
12/28/11 |
San Diego
|
|
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles
|
Luke Timmerman |
12/23/11 |
Seattle
|
|
Momenta, Baxter Team Up on Biosimilars
|
Erin Kutz |
12/23/11 |
Boston
|
|
San Diego Life Sciences Roundup: Intellikine, Somaxon, and More
|
Bruce V. Bigelow |
12/22/11 |
San Diego
|
|
The Move to Value-Based Pricing for Prescription Drugs
|
Michael Drummond |
12/21/11 |
National
|
|
Zogenix Sets Timetable for New Painkiller Drug
|
Bruce V. Bigelow |
12/20/11 |
San Diego
|
|
Anticipating FDA Clearance in 2012, Sotera Wireless Raises $12.2M
|
Bruce V. Bigelow |
12/14/11 |
San Diego
|
|
Page 1 of
32 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.